2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92546°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Neuraptive Therapeutics Announces Presentation of Phase 2 To... (2024-10-04)
Çѱ¹ ÀüÅë °¡Á׽Š¡®°®½Å¡¯ ÀçÇØ¼®ÇÑ ¡®°¡Á© °®½Å¡¯ Ãâ½Ã (2024-04-01)
¡®±â°¡ 100¸¸ ƯÁý°ü¡¯¿¡¼­ 100¸¸ ¿µÈ­ Áñ±â¼¼¿ä (2016-01-18)
IBK±â¾÷ÀºÇà-â¿øÆ¯·Ê½Ã, Áß¼Ò±â¾÷ µ¿ÇàÁö¿ø ¾÷¹«Çù¾à (2024-06-01)
Walton Global Launches Global EB-5 Immigration Program (2023-05-23)
hy, ¹è´Þ¾Û ¡®³ëÅ©¡¯ ·ÐĪ¡¦ Áö¿ª»ó»ý Ç÷§ÆûÀ¸·Î À°¼º (2024-06-30)
µ¿±¸¹ÙÀÌ¿ÀÁ¦¾à, °í¿ë³ëµ¿ºÎ Àå°ü»ó ¼ö»ó (2023-11-25)
±¹¸³±ØÀå, ¿¹¼ú±³À° ÇÁ·Î±×·¥ ¼ö°­»ý ¸ðÁý (2024-01-25)
BNKºÎ»êÀºÇà, 2024³â ¡®BNK°¡À»¾ß±¸Á¤±â¿¹±Ý¡¯ Ãâ½Ã (2024-03-26)
·¡ÄÚµå û´ã ÆË¾÷½ºÅä¾î 1ÁÖ³â, ¸®ÄÝ·ºÆ¼ºê ÆË¾÷ ÁøÇà (2024-05-26)
°¡Àüµµ ±¸µ¶ ½Ã´ë¡¦ GS¼¥, ¡®LGÀüÀÚ °¡Àü ±¸µ¶¡¯ ·ÐĪ (2023-11-19)
¡®°íµù¾öºü4¡¯ û¼Ò³â ¾ö¸¶ ¼®ÂùÈñ, Ä£Á¤¾Æ¹öÁö¿Í ¡®¿À¿­¡¯ (2023-09-16)
Interactive Brokers Introduces Enhancements to Global Bond O... (2024-08-27)
·¹µåÆäÀ̽º, °¡À» »êÇà µ½´Â °£Àý±â ¾Æ¿ôµµ¾î º£½ºÆ® Ãâ½Ã (2023-10-15)
±è½Âȯ Á¶°¢°¡ ÀÛǰ, ½Ãµå´Ï ¡®Çغ¯Á¶°¢Àü¡¯¿¡ ÃÊû (2016-11-07)
Gradiant Announces ProtiumSource, the World¡¯s Most Complete... (2024-10-27)
Organon & Lilly Expand Migraine Commercialization Agreement ... (2024-08-24)
½´ÆÛÆÐºê¸¯ Àû¿ëÇÑ Àü¹®°¡¿ë ·¹µåÆäÀ̽º µî»êÈ­ (2018-10-26)
³óÃÌÁøÈïû, ¾ÆÇÁ¸®Ä« ¾ç°è »ê¾÷ º»°Ý Áö¿ø (2015-10-25)
ÇýÀÏ ½º´ÔÀÇ ¡®°üÀ½À½¾ç¿ÀÇà Á¶Àý¹ý¡¯ (2015-06-30)
KOTRA, īŸ¸£¿Í ¡®°æÁ¦Çù·Â ´Ù°¢È­¡¯ ÃßÁøÇÑ´Ù (2023-11-04)
¿À¶Ñ±â, ÄÅ¹ä ¡®¾óÅ«¼øÈÄÃßµÅÁö±¹¹ä¡¯ Ãâ½Ã (2024-02-08)
aT, Çѱ¹ ¼Ò½ºÀÇ ¿ì¼ö¼º ¾Ë¸°´Ù (2016-11-02)
[°æÁ¦] ž籤 ½Ã´ëÀÇ ¿©¸íÀÌ ¹à¾Æ¿À°í ÀÖ´Ù (2015-05-28)
Mouser Explores the Potential of Machine Vision in its lates... (2024-04-09)
       [ÀÌÀü][1]....[795][796][797][798][799][800][801][802][803]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..